PL2132221T3 - Przyłączone do matrycy peptydomimetyki - Google Patents

Przyłączone do matrycy peptydomimetyki

Info

Publication number
PL2132221T3
PL2132221T3 PL07701901T PL07701901T PL2132221T3 PL 2132221 T3 PL2132221 T3 PL 2132221T3 PL 07701901 T PL07701901 T PL 07701901T PL 07701901 T PL07701901 T PL 07701901T PL 2132221 T3 PL2132221 T3 PL 2132221T3
Authority
PL
Poland
Prior art keywords
tyr
template
dpro
cys
ala
Prior art date
Application number
PL07701901T
Other languages
English (en)
Inventor
Steven J Demarco
Reshmi Mukherjee
Kerstin Moehle
John Anthony Robinson
Heiko Henze
Barbara Romagnoli
Daniel Obrecht
Frank Gombert
Christian Ludin
Jan Wim Vrijbloed
Original Assignee
Polyphor Ltd
Univ Zuerich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polyphor Ltd, Univ Zuerich filed Critical Polyphor Ltd
Publication of PL2132221T3 publication Critical patent/PL2132221T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Non-Reversible Transmitting Devices (AREA)
PL07701901T 2007-02-28 2007-02-28 Przyłączone do matrycy peptydomimetyki PL2132221T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CH2007/000101 WO2008104090A1 (en) 2007-02-28 2007-02-28 Template-fixed peptidomimetics
EP07701901A EP2132221B1 (en) 2007-02-28 2007-02-28 Template-fixed peptidomimetics

Publications (1)

Publication Number Publication Date
PL2132221T3 true PL2132221T3 (pl) 2011-04-29

Family

ID=37891752

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07701901T PL2132221T3 (pl) 2007-02-28 2007-02-28 Przyłączone do matrycy peptydomimetyki

Country Status (20)

Country Link
US (7) US8399611B2 (pl)
EP (1) EP2132221B1 (pl)
JP (1) JP5140686B2 (pl)
KR (1) KR101479148B1 (pl)
CN (1) CN101641372B (pl)
AT (1) ATE475667T1 (pl)
AU (1) AU2007348171B2 (pl)
BR (1) BRPI0721259C1 (pl)
CA (1) CA2679414C (pl)
DE (1) DE602007008150D1 (pl)
DK (1) DK2132221T3 (pl)
EA (1) EA017583B1 (pl)
ES (1) ES2349879T3 (pl)
IL (1) IL200312A (pl)
MX (1) MX2009008843A (pl)
NO (1) NO342598B1 (pl)
NZ (1) NZ579875A (pl)
PL (1) PL2132221T3 (pl)
PT (1) PT2132221E (pl)
WO (1) WO2008104090A1 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007079597A1 (en) 2006-01-16 2007-07-19 Polyphor Ltd. Template - fixed peptidomimetics with antimicrobial activity
WO2008092281A1 (en) 2007-01-29 2008-08-07 Polyphor Ltd. Template-fixed peptidomimetics
CN101641372B (zh) * 2007-02-28 2012-11-28 波利弗尔有限公司 模板固定的肽模拟物
WO2010127704A1 (en) * 2009-05-07 2010-11-11 Polyphor Ag Beta-hairpin peptidomimetics having cxcr4 antagonizing activity
WO2011066869A1 (en) * 2009-12-04 2011-06-09 Polyphor Ag Beta-hairpin peptidomimetics
KR20200016407A (ko) 2011-05-16 2020-02-14 젠자임 코포레이션 Cxcr4 길항제의 용도
MX343205B (es) * 2011-06-07 2016-10-28 Polyphor Ag Peptidomiméticos de horquilla beta como antagonistas de cxc4.
US9957297B2 (en) * 2011-10-07 2018-05-01 Polyphor Ag Template-fixed peptidomimetics as inhibitors of FPR1
EP2859012B1 (en) 2012-06-06 2017-08-09 Polyphor AG Beta-hairpin peptidomimetics
EP2882770B1 (en) * 2012-08-08 2017-05-31 Polyphor AG Combinations with a backbone-cyclized peptide
WO2019156137A1 (ja) 2018-02-08 2019-08-15 株式会社ステムリム 乾癬の治療薬
US12304933B2 (en) 2018-10-05 2025-05-20 StemRIM Inc. Disease treatment drug based on mesenchymal-stem-cell mobilization
US20220009976A1 (en) * 2018-10-05 2022-01-13 StemRIM Inc. Peptide Possessing Mesenchymal-Stem-Cell Mobilizing Activity
WO2022106061A1 (en) 2020-11-19 2022-05-27 Polyphor Ag Pharmaceutical combinations comprising a peptide cxcr4 inhibitor and a taxane for treating cancer
WO2022184320A2 (en) 2021-03-03 2022-09-09 Spexis Ag Medical use of cyclic peptides
WO2023285681A1 (en) 2021-07-16 2023-01-19 Spexis Ag Pharmaceutical combinations for treating cancer
WO2023285677A1 (en) 2021-07-16 2023-01-19 Spexis Ag Pharmaceutical combinations for treating cancer
WO2025068348A1 (en) 2023-09-27 2025-04-03 Spexis Ag Pharmaceutical combination of cxcr4 and pd-1 inhibitors for treating cancer
WO2025068346A1 (en) 2023-09-27 2025-04-03 Spexis Ag Pharmaceutical combination of cxcr4, pd-1 and fak inhibitors for treating cancer

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1367789B (zh) 1999-08-30 2012-06-06 波利弗尔股份公司 模板固定的β-发夹环模拟物的合成
ES2527339T3 (es) 2001-02-23 2015-01-23 Polyphor Ltd. Peptidomiméticos fijados a patrón con actividad antimicrobiana
CN101157924A (zh) 2001-12-11 2008-04-09 人体基因组科学有限公司 嗜中性白细胞因子α
CA2472580A1 (en) * 2002-01-07 2003-07-17 Sequoia Pharmaceuticals Broad spectrum inhibitors
CA2496215C (en) 2002-08-20 2013-07-16 Universitaet Zuerich Template-fixed peptidomimetics with antibacterial activity
US7855179B2 (en) 2002-10-02 2010-12-21 Polyphor Ltd. Template-fixed peptidomimetics with antimicrobial activity
ES2306924T3 (es) 2003-05-02 2008-11-16 Polyphor Ag Peptidomimeticos fijados a una matriz como medicamentos contra el vih y el cancer.
AU2003232253A1 (en) 2003-05-02 2004-11-23 Polyphor Ag Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity
US7681235B2 (en) 2003-05-19 2010-03-16 Radware Ltd. Dynamic network protection
US7994118B2 (en) 2003-11-15 2011-08-09 Polyphor Ltd. Template fixed beta-hairpin loop mimetics and their use in phage display
NZ556747A (en) 2005-02-17 2009-09-25 Polyphor Ltd Template-fixed beta-hairpin peptidomimetics with protease inhibitory acitivity
WO2006117011A1 (en) 2005-05-02 2006-11-09 Polyphor Ltd. Dye conjugates of template-fixed peptidomimetics
WO2007079597A1 (en) 2006-01-16 2007-07-19 Polyphor Ltd. Template - fixed peptidomimetics with antimicrobial activity
WO2008092281A1 (en) 2007-01-29 2008-08-07 Polyphor Ltd. Template-fixed peptidomimetics
CN101641372B (zh) * 2007-02-28 2012-11-28 波利弗尔有限公司 模板固定的肽模拟物
AU2008360223B2 (en) 2008-08-08 2014-06-19 Polyphor Ag Template-fixed peptidomimetics
WO2010060479A1 (en) 2008-11-26 2010-06-03 Polyphor Ag Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity
WO2010127704A1 (en) 2009-05-07 2010-11-11 Polyphor Ag Beta-hairpin peptidomimetics having cxcr4 antagonizing activity
AU2009350857A1 (en) 2009-08-05 2012-02-02 Polyphor Ag Conformationally constrained, fully synthetic macrocyclic compounds
WO2011060832A1 (en) 2009-11-20 2011-05-26 Polyphor Ag Template-fixed peptidomimetics with ccr10 antagonistic activity
WO2011066869A1 (en) 2009-12-04 2011-06-09 Polyphor Ag Beta-hairpin peptidomimetics
WO2011095218A1 (en) 2010-02-05 2011-08-11 Polyphor Ag Template-fixed pep tidomime tics with cxcr7 modulating activity
WO2011095220A1 (en) 2010-02-05 2011-08-11 Polyphor Ag Template - fixed peptidomimetics with cxcr7 modulating activity
WO2012016595A1 (en) 2010-08-05 2012-02-09 Polyphor Ag β-HAIRPIN PEPTIDOMIMETICS
MX343205B (es) 2011-06-07 2016-10-28 Polyphor Ag Peptidomiméticos de horquilla beta como antagonistas de cxc4.
US9957297B2 (en) 2011-10-07 2018-05-01 Polyphor Ag Template-fixed peptidomimetics as inhibitors of FPR1
US10017481B2 (en) 2012-03-17 2018-07-10 Polyphor Ag Conformationally constrained, fully synthetic macrocyclic compounds
EP2859012B1 (en) 2012-06-06 2017-08-09 Polyphor AG Beta-hairpin peptidomimetics
KR102142870B1 (ko) 2012-08-08 2020-08-11 폴리포 리미티드 백본-고리형 펩타이드와의 조합물
EP2882770B1 (en) 2012-08-08 2017-05-31 Polyphor AG Combinations with a backbone-cyclized peptide
EA035407B1 (ru) 2013-03-30 2020-06-09 Полифор Аг Бета-шпилечные пептидомиметики
JP6785651B2 (ja) 2013-03-30 2020-11-18 ポリフォー・アクチェンゲゼルシャフトPolyphor Ag ベータ−ヘアピンペプチド模倣体
SG11201605186QA (en) 2013-12-27 2016-07-28 Polyphor Ag Beta-hairpin peptidomimetics as selective elastase inhibitors
NZ722025A (en) 2013-12-27 2019-06-28 Polyphor Ag Beta-hairpin peptidomimetics as selective elastase inhibitors

Also Published As

Publication number Publication date
JP5140686B2 (ja) 2013-02-06
HK1138011A1 (en) 2010-08-13
US10787486B2 (en) 2020-09-29
US20100048463A1 (en) 2010-02-25
KR101479148B1 (ko) 2015-01-05
CA2679414C (en) 2014-10-28
NZ579875A (en) 2012-02-24
US20130150299A1 (en) 2013-06-13
US20190100558A1 (en) 2019-04-04
US9879047B2 (en) 2018-01-30
NO20093064L (no) 2009-09-28
CA2679414A1 (en) 2008-09-04
US20180127467A1 (en) 2018-05-10
PT2132221E (pt) 2010-10-26
CN101641372A (zh) 2010-02-03
DE602007008150D1 (de) 2010-09-09
EA200901178A1 (ru) 2010-04-30
BRPI0721259B1 (pt) 2020-04-07
EP2132221B1 (en) 2010-07-28
JP2010519331A (ja) 2010-06-03
ATE475667T1 (de) 2010-08-15
AU2007348171A1 (en) 2008-09-04
US10144765B2 (en) 2018-12-04
BRPI0721259A2 (pt) 2013-01-15
IL200312A (en) 2014-11-30
AU2007348171B2 (en) 2012-09-06
BRPI0721259C1 (pt) 2021-05-25
KR20100014596A (ko) 2010-02-10
US11421001B2 (en) 2022-08-23
US20170096453A1 (en) 2017-04-06
EA017583B1 (ru) 2013-01-30
DK2132221T3 (da) 2010-11-22
US20150080317A1 (en) 2015-03-19
MX2009008843A (es) 2009-08-28
US8921325B2 (en) 2014-12-30
US9556234B2 (en) 2017-01-31
NO342598B1 (no) 2018-06-18
US20200399317A1 (en) 2020-12-24
BRPI0721259B8 (pt) 2020-09-15
ES2349879T3 (es) 2011-01-12
EP2132221A1 (en) 2009-12-16
IL200312A0 (en) 2010-04-29
CN101641372B (zh) 2012-11-28
WO2008104090A1 (en) 2008-09-04
US8399611B2 (en) 2013-03-19

Similar Documents

Publication Publication Date Title
IL200312A0 (en) Template-fixed peptidomimetics
MY199965A (en) Bridged bicyclic inhibitors of menin-mll and methods of use
EP4219449A3 (en) Substituted indole derivatives and methods of preparation thereof
UA106318C2 (ru) Производный полипептид il-2 с агонистической активностью для лечения рака и хронических инфекций
WO2011133879A3 (en) Combination therapies with mitochondrial-targeted anti-tumor agents
MX2011008869A (es) Derivados de indol como antagonistas del receptor de la molecula homologa a receptor de quimioatrayente expresada en celulas th2.
WO2010009892A8 (en) Compositions for the treatment of pain and/or inflamation
NZ603196A (en) Methods of use of soluble cd24 for therapy of rheumatoid arthritis
HK1210422A1 (en) Compositions and methods for treating cutaneous scarring
MY163055A (en) Polycyclic antagonists of lysophosphatidic acid receptors
MX2009003129A (es) Derivados de oxadiazol con propiedades anti-inflamatorias e inmunosupresoras.
PH12012500572A1 (en) Polycyclic compounds as lysophosphatidic acid receptor antagonists
MX2007012237A (es) Amilina y agonistas de amilina para tratar enfermedades y trastornos siquiatricos.
WO2006129085A3 (en) High affinity melan-a t cell receptors
PL2026803T3 (pl) Kompozycje R(+) i S(-) pramipeksolu i sposoby ich zastosowania
WO2011133815A3 (en) Composite scanning mirror systems
WO2009020521A3 (en) Identification and treatment of estrogen responsive prostate tumors
WO2018215525A8 (en) Mic-1 compounds and uses thereof
GEP20247585B (en) Furoindazole derivatives
MX2020011986A (es) Composiciones que comprenden glucosa y hemicelulosa y su uso.
EP2510941A3 (en) Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist
MX2021004883A (es) Metodos y composiciones para tratar apnea del sue?o.
WO2008049098A3 (en) ANTIBODY ANTAGONISTS OF INTERLEUKIN-13 RECEPTOR α1
NZ595271A (en) Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases
WO2012088220A3 (en) Expression of thrombin variants